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Abstract
Translin and TRAX proteins play roles in very important cellular processes such as DNA recombination, spatial and temporal
expression of mRNA, and in siRNA processing. Translin forms a homomeric nucleic acid binding complex and binds to
ssDNA and RNA. However, a mutant translin construct that forms homomeric complex lacking nucleic acid binding activity
is able to form fully active heteromeric translin-TRAX complex when co-expressed with TRAX. A substantial progress has
been made in identifying translin sites that mediate its binding activity, while TRAX was thought not to bind DNA or RNA on
its own. We here for the first time demonstrate nucleic acid binding to TRAX by crosslinking radiolabeled ssDNA to
heteromeric translin-TRAX complex using UV-laser. The TRAX and translin, photochemically crosslinked with ssDNA, were
individually detected on SDS-PAGE. We mutated two motifs in TRAX and translin, designated B2 and B3, to help define the
nucleic acid binding sites in the TRAX sequence. The most pronounced effect was observed in the mutants of B3 motif that
impaired nucleic acid binding activity of the heteromeric complexes. We suggest that both translin and TRAX are binding
competent and contribute to the nucleic acid binding activity.
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Introduction
TRAX protein was initially identified in a yeast two hybrid
screen as a protein that interacts with translin, a ssDNA and RNA
binding protein [1–3]. Translin and TRAX proteins share
homology and have been evolutionarily conserved in eukaryotes
[4–6]. Evidence that these endogenous proteins interact in vivo has
been provided by immuno- precipitation studies [7,8]. Further-
more, deletion of translin in mice leads to complete loss of TRAX
protein, without affecting TRAX mRNA levels, indicating that the
stability of TRAX protein is dependent on its interaction with
translin [9,10]. Similar results have been reported in Drosophila
melanogaster (drosophila) and Schizosaccharomyces pombe (S. pombe)
demonstrating that the close interaction between translin and
TRAX has been conserved over the course of evolution [11,12].
As the translin-TRAX complex binds to both ssDNA and RNA,
it has been implicated in a variety of cellular functions. Initially, it
was thought that its ability to bind to ssDNA indicated its
involvement in DNA repair [3,13]. This view has been supported
by the observation that DNA damaging agents induce TRAX’s
interaction with the nuclear C1D as a part of a cellular DNA
repair response [14]. As the complex also binds to RNA in vitro,
two recent studies have focused attention on its possible role in
regulating RNA trafficking and processing. One provides evidence
that the complex mediates dendritic trafficking of BDNF mRNA, a
transcript that plays a critical role in synaptic plasticity processes
[15]. The other suggests that the translin-TRAX complex
functions as a key activator of siRNA-mediated silencing in
drosophila [16]. In addition, TRAX has been found to suppress
proliferation of PC12 cells in the presence of p53 blockade [17]
and to regulate mRNA levels encoding growth-associated protein
(GAP)-43 in retinal ganglion cells [18]. Also TRAX interacts with
mammalian phospholipase Cb1 [19].
To understand how the translin-TRAX complex exerts its
cellular effects, it would be helpful to define how it binds to ssDNA
or RNA. Initial characterization of translin and TRAX revealed
that translin, but not TRAX alone, is able to form a homomeric
complex capable ofbindingssDNA orRNA.Analysisofthe human,
mouse or yeast translin homomeric complexes demonstrated that
they form octameric complexes, while chicken translin forms a
decameric complex [20]. Furthermore, substantial progress has
been made in identifying nucleic acid binding sites in translin
homomericcomplexes. Forexample,mutationsof residuesinone of
the basic domains, referred to as basic-2 (translinB2 here), markedly
reduces the ssDNA or RNA binding activity of the translin
homomeric complex [20]. However, translin constructs with
mutations in the B2 region are able to form heteromeric complexes
with TRAX that are fully active in gel-shift binding assays [6,21].
Also, heteromeric complex between wild-type translin and TRAX
proteins showed stronger binding to DNA than RNA [21,22]. The
TRAX protein possesses nuclear localization signal and in the
nucleus could change its protein partners between translin and C1D
[22]. These observations hint whether physiological effects of the
TRAX are dependent on its nucleic acid binding activity, though
TRAX on its own is believed not bind to RNA or DNA [6,21,22]
We have conducted studies aimed at deducing nucleic acid
binding characteristics of TRAX and in defining the binding sites.
Our results show that TRAX binds to ssDNA and two regions in
TRAX, designated TRAXB2 and TRAXB3, mediate nucleic acid
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translin B3 motif, corresponding to TRAX B3 residues, contrib-
utes towards its DNA binding activity.
Materials and Methods
Materials
dNTPs and T4 DNA ligase were obtained from Roche
(Germany), and restriction enzymes and T4 polynucleotide kinase
from New England BioLabs (Hitchin, UK). QuickChange site-
directed mutagenesis kit and PfuTurboDNA polymerase were
obtained from Stratagene (La Jolla, USA). Plasmid pQE9 was
obtained from Qiagen (QIAGEN India Pvt. Ltd., India), E. coli
BL21(DE3) cells [E. coli BF
2 dcmompThsdS(rB
2,m B
2) gall(DE3)],
and plasmids pET21a and pET28a were obtained from Novagen
(Madison, USA). Chromatography media were obtained from
Amersham-Pharmacia (Uppsala, Sweden). Oligonucleotides for
cloning, ssDNA of Bcl-CL1 sequence, [a-
32P]GTP and
[c-
32P]ATP were synthesized at BRIT (Navi Mumbai, India).
Other fine chemicals were procured from SRL (Mumbai, India).
Prediction of DNA-binding residues
The DNA-binding sites in human TRAX and translin
sequences were predicted using the DP-Bind web-server [23;
http://lcg.rit.albany.edu/dp-bind/]. The analysis was performed
with PSSM-based encoding which uses a position-specific scoring
matrix generated by PSI-BLAST [24]. The DNA-binding residues
were identified from the consensus that retained only high
confidence predictions and were categorized in five motifs (B1–
5) on TRAX and translin sequences.
Recombinant plasmids
The pQE9-translin and pET28a-trx constructs, used to express
human translin and human TRAX, were those used earlier [25].
The constructs were kind gifts from Professors M. Kasai, National
Institute of Health, Tokyo, Japan and N.B. Hecht, University of
Pennsylvania, USA, respectively. Mutants of the putative nucleic
acid binding motifs B2 and B3 on the TRAX sequence,
(TRAXB2-
115QFHRA
119 to
115LFNAA
119)( pET28a-trxB2 con-
struct) and (TRAXB3-
241KKLY
244 to
241NTLN
244)( pET28a-
trxB3 construct), were synthesized by QuickChange site-directed
mutagenesis kit using pET28a-trx as template and complementary
primers pairs (Table S1). The constructs were used to express
TRAX variants with poly-histidine (66His) tag at their N-termini.
Mutants of the B2 and B3 nucleic acid binding motifs on the
translin sequence, (translinB2;
86RFHEH
90 to
86TFNEN
90)
(pQE9-translinB2 construct) and (translinB3;
192RKRY
195 to
192TNSN
195)( pQE9-translinB3 construct), were synthesized by
the PCR overlap extension method using the overlapping primer
pairs (Table S1). The constructs pET21a-translin, pET21a-trans-
linB2 and pET21a-translinB3, were also synthesized by cloning
mutant and wild-type translin genes into the NdeI and BamHI sites
of pET21a plasmid to express translin proteins without any tag, to
be used for co-expression system. The nucleotide sequences of all
the cloned genes were confirmed by DNA sequencing using an
ABI automated DNA sequencer. A summary of all the constructs
used for testing DNA binding activity is listed in Table 1.
Expression and purification of the proteins
The E. coli BL21(DE3) cells harboring pET21a-translin were co-
transformed with pET28a-trx, pET28a-trxB2 or pET28a-trxB3
constructs to express the complexes of wild-type human translin
with wild-type or mutant TRAX proteins. Similarly, the
complexes of human mutant translin (translinB2 or translinB3)
with TRAX (wild type or mutants) were expressed by co-
transforming the pET28a-trx, pET28a-trxB2 or pET28a-trxB3 into
the E. coli BL21 (DE3) cells harboring pET21a-translinB2 or
Table 1. Details of the constructs and expression systems used, and ssDNA binding characteristics of the purified proteins.
Protein/Complex (abbreviation) Expression system Activity
1
Human translin (translin) pQE9-translin transformed into E. coli BL21 (DE3) +++
Mutant of basic-2 motif of human translin (translinB2) pQE9-translinB2 transformed into E. coli BL21 (DE3) ND
2
Mutant of basic-3 motif of human translin (translinB3) pQE9-translinB3 transformed into E. coli BL21 (DE3) ND
Complex of human translin and TRAX proteins (translin-TRAX) pET21a-translin and pET28a-trx co-transformed into E. coli BL21(DE3) ++++
Complex of human translin with human B2 mutant TRAX
(translin-TRAXB2)
pET21a-translin and pET28a-trxB2 co-transformed into E. coli BL21(DE3) ++++
Complex of human translin with human B3 mutant TRAX
(translin-TRAXB3)
pET21a-translin and pET28a-trxB3 co-transformed into E. coli BL21(DE3) +
Complex of human B2 mutant translin with human TRAX
(translinB2-TRAX)
pET21a-translinB2 and pET28a-trx co-transformed into E. coli BL21(DE3) ++++
Complex of human B2 mutant Translin with human
B2 mutant TRAX (translinB2-TRAXB2)
pET21a-translinB2 and pET28a-trxB2 co-transformed into E. coli BL21(DE3) +++
Complex of human B2 mutant translin with human
B3 mutant TRAX (translinB2-TRAXB3)
pET21a-translinB2 and pET28a-trxB3 co-transformed into E. coli BL21(DE3) ND
2
Complex of human B3 mutant translin with human
TRAX (translinB3-TRAX)
pET21a-translinB3 and pET28a-trx co-transformed into E. coli BL21(DE3) ND
Complex of human B3 mutant Translin with human
B2 mutant TRAX (translinB3-TRAXB2)
pET21a-translinB3 and pET28a-trxB2 co-transformed into E. coli BL21(DE3) ND
Complex of human B3 mutant translin with human
B3 mutant TRAX (translinB3-TRAXB3)
pET21a-translinB3 and pET28a-trxB3 co-transformed into E. coli BL21(DE3) ND
ND-Activity was not detected under experimental conditions using radiolabeled ssDNA.
1The relative DNA-binding activity represented as four bins of 25% each.
2Weak activity detected with higher concentrations of proteins and DNA.
doi:10.1371/journal.pone.0033035.t001
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as 66His-TRAX complexed with untagged translin. The co-
transformants were selected and maintained using two antibiotics,
based on the resistances conferred by the transforming vectors.
The homomeric translin proteins (wild-type translin, translinB2
mutant or translinB3 mutant) were expressed with N-terminal
66His tag in E. coli BL21(DE3) cells harboring pQE9 constructs
(pQE9-translin, pQE9-translinB2 or pQE9-translinB3). The expres-
sion of translin and TRAX proteins was induced by isopropyl-b-
D-1-thio galactopyranoside (IPTG). Translin proteins or translin-
TRAX complexes (Table 1) were purified using chelating-
sepharose FF column (Nickel(II)-iminodiacetic acid; Ni-IDA)
followed by anion-exchange high Q-sepharose column chroma-
tography. The purified proteins were incubated with DNase1 and
RNaseA overnight at 20uC followed by purification using Ni-IDA
column. The purification protocol for heteromeric complexes
ensured recovery of only the translin-TRAX complexes from the
affinity matrix because translin was untagged and 66His tagged
TRAX was insoluble when expressed alone.
Gel filtration and Circular dichroism analysis
The purified translin proteins and translin-TRAX complexes
were loaded on the Superdex
TM 200 10/300 GL column (GE
Healthcare) for final purification step as well as for molecular
weight determination. The Superdex
TM 200 column was calibrat-
ed with gel filtration molecular weight markers (Amersham-
Pharmacia; Carbonic anhydrase, 29 kDa; Alcohol dehydrogenase,
150 kDa; b-amylase, 200 kDa; Ferritin, 440 kDa). The eluted
peak of each independent gel filtration experiment was adjudged
on SDS-PAGE. The purified proteins were concentrated to 5–
7m gm L
21. The protein concentrations were estimated by
modified Lowry’s method [26] using bovine serum albumin
(BSA) as the standard.
The far-UV circular dichroism (CD) spectra for the purified
translin proteins (0.3 mg mL
21) and translin-TRAX complexes
(0.3 mg mL
21) were recorded in the wavelength range of 200–
260 nm at 25uC with JASCO spectro-polarimeter (model J-810).
Each spectrum was averaged for three scans. The observed spectra
were deconvoluted into their secondary structure content using
K2D2 software [27].
DNA-binding assay
Electrophoresis mobility shift assays (EMSA) were performed to
assess DNA binding-activity of the DNase1 and RNaseA treated
proteins/complexes using Bcl-CL1 ssDNA (GCCCTCCTGC-
CCTCCTTCCGCGGG) as probe. The molecular masses of the
heteromeric complexes used were ,300 kDa, whereas oligomers
of human translin were 236 kDa, respectively. The probe was 59
end-labeled using T4 polynucleotide kinase (3 U reaction
21) and
[c-
32P]ATP in a 50 mL reaction buffer at 37uC for 60 minute
followed by heat inactivation of the enzyme at 65uC for
30 minutes. The radiolabeled probe was purified by spin column
MicroSpin
TM G-25 (GE Healthcare). Translin (50 nM of
octameric translin) and translin-TRAX complexes (100 nM of
300 kDa translin-TRAX complex) were incubated with the
labeled-DNA probe (100 nM) in binding buffer B1 (25 mM
Tris-HCl pH 8.0, 100 mM NaCl, 1 mM EDTA) for 30 minute.
The 10 mL of reaction mixtures were separated by electrophoresis
on a 4.5% native-PAGE in 0.56Tris-borate-EDTA (TBE) buffer.
The dried gels were exposed to X-ray film overnight. The intensity
of the shifted DNA-protein complexes was estimated using a gel
documentation system from Syngene (Synoptics, Cambridge,
England).
The identity of proteins in gel-shifted bands from the EMSA
analysis performed with 100-fold higher concentrations of DNA
and proteins was adjudged by SDS-PAGE analysis. The DNA in
this experiment was stained with ethidium bromide and varying
concentrations of translin proteins (1 and 5 mM) and translin-
TRAX complexes (2 and 10 mM) were incubated with 10 mMo f
the 24-mer unlabeled-DNA oligo in 20 mL reaction volume for
30 minutes. The products were resolved by electrophoresis on
1.5% agarose gel and stained with ethidium bromide. The agarose
regions containing gel-shifted bands were excised and adjudged on
12% SDS-PAGE, which confirmed that both translin and TRAX
proteins were components of translin-TRAX:DNA complexes.
Photochemical crosslinking and purification of TRAX-
DNA covalent complex
To detect the direct binding of ssDNA with TRAX, the
radiolabeled DNA probe was crosslinked with translin-TRAX
complex using KrF excimer UV laser (COMPexPro 205) at
248 nm. Translin (50 pmol of octameric translin) and translin-
TRAX complexes (50 pmol of the 300 kDa heteromeric complex)
were individually incubated with 50 pmol of labeled-DNA probe for
30 min in 50 mL binding buffer (25 mM Tris-HCl pH 8.0, 100 mM
NaCl, 1 mM EDTA). Each of the protein:DNA mixtures were
irradiated in a quartz cell (Eppendorf UVette) for 1 minute at 1-
pulse/sec imparting about 2400 mJ of total energy. BSA:DNA
mixture was also irradiated under identical conditions as a negative
control. To isolate TRAX-DNA crosslinked complex, the irradiated
heteromeric complex was disrupted in the presence of 8 M urea
followedby5 minutesincubationinboilingwaterbath.Thereaction
mixture was loaded onto Ni-IDA spin-column pre-equilibrated with
binding buffer (25 mM Tris-HCl, pH 8.0, 8 M urea, 50 mM
imidazole and 100 mM NaCl). The matrix beads were extensively
washed with binding buffer. The bound protein was eluted with
elution buffer (25 mM Tris-HCl, pH 8.0, 8 M urea, 1 M imidazole
and 100 mM NaCl). This protocol resulted in purification of
denatured TRAX and its covalent complexes as the 66His tag was
fused only with TRAX sequence. The purification of TRAX alone
was further confirmed by mass spectrometry of the purified protein
component obtained by disrupting pure translin-TRAX complex in
an independent experiment. The TRAX-DNA complex along with
irradiated translin-DNA complex and pre-stained molecular weight
markers were resolved on 12% SDS-PAGE. The dried gel was
autoradiographed onX-rayFilm.The positionsofTRAX-DNAand
translin-DNA complexeson autoradiographoftheSDS-PAGEwere
estimated from the mobility of the pre-stained marker proteins. To
adjudge the extent of protein-protein crosslinking, purified translin
was mixed with [a-
32P]GTP and the mixture was irradiated for
2400 mJ laser energy under conditions identical to that for protein-
DNA complexes.
Results
Prediction of DNA-binding residues on TRAX
Candidate DNA-binding residues in the human TRAX protein
were identified based on the consensus sites detected by the DP-
Bind web server. This algorithm predicted most of the 22 N-
terminus amino acids as DNA-binding residues, as well as five
additional DNA binding motifs (B1,
75HRITS
79; B2,
115QFHRA
119; B3,
237YEVSKKL
243; B4,
247KQSLAK
252 and
B5,
261KVRGS
265). The five motifs (B1–5) were also predicted to
be present in human translin sequence (Fig. 1). The previous
studies had demonstrated that substitutions in B2 and B3 motifs in
translin, identified here, resulted in loss of ssDNA binding activity
[21,28]. The B2/B3 motifs of TRAX are disposed similar to those
DNA Binding Sites on TRAX
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heterodimer (Fig. 2). Accordingly, to test the role of the B2 and
B3 motifs of TRAX in nucleic acid binding activity of the
heteromeric translin-TRAX complex, we generated TRAX
constructs in which amino acid residues of either the B2 or B3
motifs were mutated as follows: TRAXB2 -
115QFHRA
119 to
115LFNAA
119; TRAXB3 -
241KKLY
244 to
241NTLN
244.
Oligomeric status and structural content of translin-TRAX
complexes
Prior to testing the impact of these mutations in TRAX on the
nucleic acid binding activity of the translin-TRAX complex, we
checked whether they altered its size or composition. The
molecular masses of the heteromeric complexes formed by translin
variants with either wild type TRAX or TRAXB2 or TRAXB3
proteins were determined to be ,300 kDa by gel-filtration
chromatography (Fig. 3A). The eluted proteins were adjudged
on 12% SDS-PAGE. The intensities of translin and TRAX bands
showed nearly equimolar ratio of the two proteins in the
heteromeric complexes (Fig. 3B). By comparison, the molecular
mass of homomeric translin complexes generated by either wild-
type translin or translin constructs containing mutations in B2 or
B3 domains (
86RFHEH
90 to
86TFNEN
90;
192RKRY
195 to
192TNSN
195) were determined to be approximately 236 kDa,
consistent with earlier reports that mutations in the basic-2 (B2)
motif do not affect the octameric status of human translin [20].
We compared the CD spectra of homomeric translin and
heteromeric translin-TRAX complexes and found excellent
agreement between CD spectra of heteromeric and homomeric
complexes in the wavelength range of 200–260 nm with the
known crystal structures of translin and translin-TRAX complexes
(Fig. 4). The observed characteristic negative bands of a-helical
proteins at 222 nm and 208 nm are in conformity with all-helical
structure of translin and TRAX proteins. The CD analysis also
suggests that mutations in the nucleic acid binding motifs of
translin and TRAX do not alter the secondary structural content
of the complexes.
DNA-binding activity
The DNA-binding activities of homomeric translin and
heteromeric translin-TRAX complexes were monitored by
electrophoresis mobility shift assays using the Bcl-CL1 probe,
which is a 24-mer ssDNA oligo used in initial studies character-
izing the nucleic acid binding properties of translin and TRAX
[3]. Two bands with retarded migration (bands 1 and 2) were
observed for the active protein complexes, compared to DNA
alone (lane 1, Fig. 5A). However, intensity of the slow migrating
band 2 was very weak, compared to band 1. Band 2 thus
corresponded to higher oligomer observed in low-abundance in
gel-filtration and native-PAGE analyses (Fig. S1) of the pure
proteins. Similar band pattern was also observed in earlier studies
aimed to deduce the nucleic acid binding properties of translin or
translin-TRAX complex proteins [20,21]. The heteromeric
translin-TRAX complex displayed enhanced ssDNA binding
activity compared to the homomeric translin complex (lanes 3
and 2; Fig. 5A). To test the predicted role of the B2 and B3 motifs
of TRAX in nucleic acid binding activity, we examined the ssDNA
binding activities of the heteromeric complexes formed by wild
type translin with the TRAXB2 or TRAXB3 mutant constructs
(Table 1). While the binding activity displayed by the translin-
TRAXB2 complex is comparable to that of the wild type translin-
TRAX complex (lane 4), the binding activity of the translin-
TRAXB3 complex is markedly reduced (lane 5, Fig. 5A).
We further tested the effect of substitutions in B2/B3 motifs of
TRAX in DNA binding ability of the heteromeric complex
constructed using translinB2 or translinB3 mutants. Interestingly,
both wild type TRAX and TRAXB2 mutants could rescue activity
of translin B2 mutation (Fig. 5A, lanes 8 and 9; Fig. 5B, lanes 9
Figure 1. Alignment of TRAX and translin sequences. The amino acid sequences of the TRAX and translin proteins of human and drosophila
(UniProtKB/Swiss-Prot Q99598, Q8INE1, Q15631 and Q7JVK6, respectively) were aligned by ClustalW [33]. For clarity, only sequences of human TRAX
(TRAX) and human translin (translin) are shown. The identical amino acid residues are shaded and similar residues are boxed. The five putative DNA
binding regions (B1–5) predicted by the DP-Bind server and the nuclear localization signal (NLS) on the TRAX sequence are identified. Also marked are
five basic regions (B1–5) on translin sequence and its nuclear export signal (NES). The figure was prepared with ESPript [34].
doi:10.1371/journal.pone.0033035.g001
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were observed to be fully inactive in the study with radiolabeled
ssDNA probe (lane 10, Fig. 5A). Consistent with previous studies,
homomeric mutant translinB2 did not show any DNA binding
activity when used in low concentration with the radiolabeled
probe (lane 7, Fig. 5A). Also, translinB3 mutant did not show
detectable DNA binding activity (Fig. S2). Similar results were
reported for the S. pombe translin where substitution in R210 and
R211 (equivalent to R192 and K193 of human translinB3 motif)
dramatically reduced DNA-binding activity [28]. Surprisingly,
neither of the wild-type translin or TRAX proteins could rescue
activity of TRAXB3 or translinB3 mutants (Fig. S2). To detect
weak binding affinities, the assays were also performed with high
concentrations of unlabeled DNA (10 mM) and proteins (typically,
1 and 5 mM of octameric translin proteins, and 2 and 10 mMo f
octamer of heteromeric complex). Although the band intensities
showed trend of binding affinities similar to that observed with
labeled DNA, however, weak binding was detected even with the
heteromeric translinB2-TRAXB3 and homomeric translinB2
mutants (Fig. 5B). Protein/complexes alone were also loaded to
confirm that detected intensity is not due to artifact.
Since very similar elution profile on gel-filtration column and
nearly identical CD-spectra were observed for all the complexes,
the data suggests that alterations in the DNA binding activities can
be attributed to the substitution in DNA binding motifs. Taken
together it can be concluded both B2 and B3 motifs of TRAX
contribute to DNA binding activity in the context of the
heteromeric complex, with mutations of the B3 site having clearly
more pronounced effect.
Photochemical crosslinking of ssDNA with TRAX
The radiolabeled ssDNA probe was crosslinked with homo-
meric translin and heteromeric translin-TRAX complex using
UV-laser. The BSA:DNA mixture was used as a negative control
in the crosslinking experiment. For unambiguous detection of
TRAX-DNA covalent complex, the irradiated heteromeric
translin-TRAX complex was disrupted by boiling with 8 M urea.
TRAX/TRAX-DNA complex was purified with Ni-IDA matrix
spin-column using 66His tag in TRAX. The protocol resulted in
purification of TRAX or its covalent complexes, as verified by
mass spectrometry. The eluent of the disrupted heteromeric
complex containing TRAX and TRAX covalent complexes, and
irradiated translin:DNA mixture were resolved on 12% SDS-
PAGE. The translin-DNA and TRAX-DNA complexes were
clearly detected on autoradiogram. The TRAX-DNA complex
(lane 3, Fig. 6), migrates close to the 44 kDa marker protein and
thus corresponds to TRAX molecule (35.3 kDa) covalently linked
with one ssDNA moiety (,7.6 kDa). As expected, yield of the
covalent complex was very poor. A band of very weak intensity
(relative to the unliganded protein) was observed on silver-stained
gel SDS-PAGE (Fig. S3). The migration of this band corresponded
to difference in the molecular masses between nucleic acid
complexed and uncomplexed TRAX protein. The UV-crosslinked
heteromeric complex with 43-mer ssDNA probe in an indepen-
dent experiment showed expected shift of ,6 kDa in the TRAX-
DNA band (Fig. S3). As compared to TRAX-DNA covalent
complex observed in autoradiogram, translin-DNA complex
migrates at about 36 kDa (lane 2, Fig. 6). No band could be
detected in lane 4 loaded with BSA:DNA irradiated sample,
suggesting that crosslinking of DNA with TRAX was not due to
artifact A very high molecular mass complex was also detected in
both the lanes. Similar high molecular mass band was also
detected at much lower concentration in the translin-[a-
32P]GTP
mixture that was irradiated under same conditions.
Discussion
The nuclease activity of translin-TRAX heteromeric complex
has been in recent focus due to its role in siRNA processing
[16,29]. A number of studies also provided evidence that TRAX
and translin play important role in DNA damage recovery [12–
14]. The functional role of these proteins vis-a `-vis their DNA-
binding ability has also been argued recently [22]. Binding of
DNA to the translin-TRAX complex has been thought to be
mediated through translin, and TRAX was not expected to bind
the nucleic acid substrates [21,22,29]. In the present study, we
Figure 2. Cartoon showing close proximity of B2 and B3 motifs
on human translin-TRAX heterodimer. Different views (A,B)o f
cartoon showing B2 and B3 motifs (spheres) of translin (cyan) and TRAX
(blue) in translin-TRAX heterodimer. The figure was prepared using
atomic coordinates of translin-TRAX complex structure (PDB code,
3PJA) and PyMol suite [35].
doi:10.1371/journal.pone.0033035.g002
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crosslinking radiolabeled ssDNA with translin-TRAX complexes
using UV-laser. The DNA binding studies were carried out with
the heteromeric complexes as TRAX alone is not stable by itself
[10,25,30]. The heteromeric complexes used in DNA-binding
studies were purified by the size exclusion column chromatogra-
phy and were of molecular masses ,300 kDa. From the relative
intensity of translin or TRAX bands on the SDS-PAGE equimolar
ratio of the two proteins in the heteromeric complexes could be
taken. Although we expect heteromeric complexes as translin4-
TRAX4 multimers, minor contamination of conformational
oligomers of compositions translin5-TRAX3 or translin6-TRAX2,
given the resolution of Superdex 200 gel filtration column, cannot
be ruled out. Post-irradiation, the heteromeric complex was
disrupted using chaotropic agent, urea, under boiling condition.
The 66His tagged TRAX/TRAX-DNA crosslinked complex was
purified by metal chelating affinity matrix under denaturing
conditions, while untagged translin was recovered in extensive
wash steps. The TRAX-DNA complex was clearly detected on
autoradiograph of SDS-PAGE analysis of the eluent. Also, the
translin-DNA covalent complex was detected in the irradiated
translin:DNA mixture. The TRAX-DNA complex migrates
corresponding to molecular mass of about 44 kDa, compared to
36 kDa translin-DNA covalent complex (Fig. 6).
Since the UV light is known to induce protein–DNA cross-
linking predominantly at their contact points, we tested the
hypothesis that the B2 and B3 motifs in TRAX play a critical role
in the nucleic acid binding activity of the heteromeric complex.
The B2 and B3 motifs of TRAX are juxtaposed to the DNA
binding B2/B3 motifs on translin in the recently resolved crystal
structures of translin-TRAX complexes [29,30] (Fig. 2). We
mutated residues of these motifs and examined the DNA binding
activity of mutant complexes. These mutations did not cause any
perturbation in structure or their oligomeric status as wild-type
and mutant complexes showed similar CD-spectra and elution
profiles on gel-filtration analysis. We found that mutations in the
TRAX B3 site drastically reduce the binding activity of the
heteromeric complex formed with wild type translin, while
mutations in the TRAX B2 site do not. However, the TRAX
B2 mutations do impair the ability of TRAX to form fully active
heteromeric complexes with the translinB2 mutant. Also, drastic
loss of DNA binding activity was observed in heteromeric complex
translinB2-TRAXB3 (Fig. 5). Lastly, homomeric or heteromeric
complexes with substitutions in the B3 motifs of translin are totally
inactive in binding assays (Fig. S2).
The DNA-binding domain of human translin is formed by
combination of its basic motifs in a multimeric structure and loss of
multimeric structure results in abrogation of its DNA binding
abilities [20]. The DNA-binding competent oligomers of translin
were earlier shown to be constituted by energetically stable and
evolutionarily conserved dimers in up-down configuration [31]. In
contrast, TRAX has been shown not to interact with itself using
yeast two hybrid system [21]. Additionally, heteromeric complexes
have been observed in a variety of TRAX/translin compositions;
translin4-TRAX4 [22], translin5-TRAX3 and translin6-TRAX2
[29] and translin4-TRAX2 [30]. The complexes are constituted by
translin-TRAX and translin-translin up-down dimers. Important-
ly, TRAX-TRAX homodimers are not observed. These observa-
tions together hint that TRAX alone cannot oligomerize. It can
thus be rationalized that DNA binding activity of TRAX could not
be detected in earlier studies since it alone could not achieve
nucleic acid binding-competent oligomeric status.
Figure 3. Gel filtration analyses of human translin and translin-TRAX complexes. A) A profile overlay of Superdex 200 gel-filtration
chromatography of human translin and translin-TRAX complexes. The major peaks corresponding to molecular masses of 295 kDa for the complexes
and 236 kDa for the translin were used for DNA-binding assays. B) The translin/TRAX protein complexes purified by gel-filtration chromatography
were adjudged on SDS-PAGE. Molecular weight markers, lane1; human translin, lane 2; translinB2-TRAXB3 complex, lane 3; translin-TRAXB3 complex,
lane 4; translinB2-TRAXB2 complex, lane 5 and wild-type translin-TRAX complex, lane 6. Nearly equimolar stochiometry of translin and TRAX proteins
in the heteromeric complexes could be estimated from the band intensities. Truncation in TRAX protein was observed on storage. The truncation site
at the C-terminus was confirmed by N-terminal sequencing and MALDI-TOF analyses. Integrated intensities of both the TRAX bands were summed to
estimate translin/TRAX stoichiometry.
doi:10.1371/journal.pone.0033035.g003
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32P]-labeled Bcl-CL1 24-mer ssDNA (100 nM) was incubated with human
translin (50 nM of octameric translin) and translin-TRAX complexes (100 nM of octameric translin-TRAX complex). The mixtures were resolved on the
4.5% native-PAGE in TBE buffer. Prior to EMSA analysis all the purified samples were treated with DNase1 and RNaseA overnight at 20uC followed by
purification using Ni-IDA chelating sepharose column. Lane 1, only DNA; lane 2, human translin; lane 3, translin-TRAX complex; lanes 4 and 5,
complexes of human translin with the B2 and B3 mutants of human TRAX (translin-TRAXB2 and translin-TRAXB3), respectively; lane 6, Blank; lane 7,
basic-2 region mutant of human translin (translinB2); lanes 8, 9 and 10, complexes of translinB2 with human TRAX, TRAXB2 and TRAXB3 (translinB2-
TRAX, translinB2-TRAXB2 and translinB2-TRAXB3), respectively. Two bands with retarded mobility, compared to DNA alone, were observed in active
protein complexes. Band 1 presumably corresponded to octameric complex while band 2 with very weak intensity belonged to higher oilgomers. B)
Unlabled Bcl-CL1 24-mer ssDNA (10 mM) was incubated with human translin (1 mM and 5 mM, lanes 2 and lane 3 respectively), wild-type translin-TRAX
complex (2 mM and 10 mM, lanes 4 and 5 respectively), translinB2 mutant (1 mM and 5 mM, lanes 6 and 7 respectively), translinB2-TRAX (2 mM and
10 mM, lanes 8 and 9 respectively), translinB2-TRAXB2 (2 mM and 10 mM, lanes 10 and 11 respectively) and translinB2-TRAXB3 (2 mM and 10 mM, lanes
12 and 13 respectively), and the reaction mixtures were resolved on 1.5% agarose gel were stained with ethidium bromide. At higher concentrations
the ssDNA binding activity of translinB2-TRAXB3 complex was weakly detectable with ethidium bromide. This was not observed in autoradiograms
with low concentrations of radiolabeled DNA and the protein complex.
doi:10.1371/journal.pone.0033035.g005
Figure 4. Circular dichroism (CD) analysis of the proteins in the wavelength range of 200–260 nm. The characteristic negative bands of
a-helical proteins at 222 nm and 208 nm are observed for all the proteins and complexes. The CD spectrum of human translin essentially overlaps
with those of translin-TRAX complexes. For clarity, CD spectra is shown for a few of the protein/complexes. The CD spectra presented are of human
translin (translin), human mutant translinB3 (translinB3), human translin-TRAX complex (translin-TRAX), and complexes of mutants of human TRAXB3
and translin (translin-TRAXB3 and translinB2-TRAXB3).
doi:10.1371/journal.pone.0033035.g004
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PLoS ONE | www.plosone.org 7 March 2012 | Volume 7 | Issue 3 | e33035The conformation of translin-TRAX heterodimer closely
resembles that of translin-translin dimer in crystal structures
[29,32] (Fig. 2 and Fig. S4). Since mutations in both of the B2 and
B3 sites abolish the nucleic acid binding activity of the complex, it
can be concluded that B2 and B3 motifs of both translin and
TRAX contribute to DNA binding activity. The identified nucleic
acid binding motifs reside on the equatorial region of the translin-
TRAX octamer. The shortest distance between DNA binding
motif and TRAX catalytic centre responsible for RNase activity of
translin-TRAX complex is about 9 A ˚ [16,29]. We anticipate that
knowledge of DNA binding domains of TRAX will help guide
future studies aimed at elucidating relationship between its high
affinity nucleic acid binding and RNase activities of the translin-
TRAX complexes.
In summary, we isolated the covalent complex of TRAX with
the probe ssDNA after disrupting the UV-irradiated heteromeric
translin-TRAX complex. We have identified the B2 and B3 sites in
TRAX as mediating its role in nucleic acid binding activity of the
heteromeric complex. We suggest that the complex is assembled
from translin-TRAX or translin-translin dimer subunits, and B2/
B3 motifs of both translin and TRAX primarily contribute to
DNA binding activity.
Supporting Information
Figure S1 Native-PAGE analysis. Human translin and its
mutants were resolved on 4.5% polyacrylamide gel under native
conditions (Lane 1, translin; lane 2, translinB3; lane 4, translinB2).
The proteins purified by three-stage chromatography were those
eluted at molecular mass of about 236 kDa from Superdex 200
column. The native-PAGE showed presence of low-abundance
high molecular mass oligomer.
(TIF)
Figure S2 DNA-binding activity of the proteins/com-
plexes. [c-
32P]-labeled Bcl-CL1 24-mer ssDNA (200 nM) was
incubated with human translin (100 nM of octameric translin) and
translin-TRAX complexes (100 nM of translin-TRAX complex).
The mixtures were resolved on the 4.5% native-PAGE in TBE
buffer. Prior to EMSA analysis all the purified samples were
treated with DNase1 and RNaseA overnight at 20uC followed by
purification using Ni-IDA chelating sepharose column. Lane 1,
human translin; lane 2, human translin-TRAX complex; lanes 3
and 4, complexes of human translin with B2 and B3 mutants of
human TRAX, respectively; lane 5, translinB2 mutant; lanes 6, 7
and 8, complexes of translinB2 mutant with wild-type human
TRAX, with B2 mutant of human TRAX and with B3 mutant of
human TRAX, respectively; lane 9, translinB3 mutant; lanes
10,11 and 12, complexes of translinB3 mutant with wild-type
human TRAX, with B2 mutant of human TRAX and with B3
mutant of human TRAX, respectively.
(TIF)
Figure S3 Supershift analysis of TRAX-DNA complex.
To confirm TRAX-DNA crosslinking, a 43-mer unlabeled DNA
was incubated with translin-TRAX complex and was UV-
irradiated. Post-irradiation, the complex was disrupted using
chaotropic agents and TRAX-DNA complex alone was purified
using 66His tag available on TRAX sequence alone. The covalent
complexes of TRAX with 43-mer DNA (lanes 4 and 5), with 24-
mer DNA (lanes 1 and 2) and molecular weight markers (lane 3)
were resolved on 12% SDS-PAGE. The protein bands were
stained with silver-stain. The relative migration of covalent
TRAX-DNA complexes (boxed, weak band intensity suggests
poor yield of the covalent complex) corresponded to the molecular
mass difference between 43- and 24- mer DNA.
(TIF)
Figure S4 Cartoon showing close proximity of B2 and
B3 motifs on up-down dimer of human translin. The two
monomers of translin are shown in cyan and blue colors. The B2
and B3 motifs are shown as spheres. The figure was prepared
using atomic coordinates of human translin structure (PDB
code,1J1J) and PyMol suite.
(TIF)
Table S1 Primer sequences used to synthesize the
mutants of translin and TRAX.
(DOCX)
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Figure 6. Autoradiograph showing protein-DNA crosslinking.
Purified translin, translin-TRAX complex and BSA were mixed with
[c-
32P]-labeled Bcl-CL1 24-mer ssDNA. The mixtures were irradiated with
UV-laser imparting total of 2400 mJ energy of 248 nm wavelength.
Post-irradiation, the translin-TRAX complex was disrupted and TRAX
was purified using affinity tag. The protein:DNA complexes (translin-
DNA, lane 2; TRAX-DNA, lane 3, BSA:DNA, lane 4) and DNA alone (lane 1)
were resolved on 12% SDS-PAGE and dried gel was autoradiographed
on X-ray film. The translin-DNA and TRAX-DNA complexes differ by
expected 6 kDa in molecular mass. The BSA, used as a negative control,
did not show presence of protein-DNA covalent complex in the post-
irradiated mixture. The intensities of free DNA band in lane 1 and 4 are
much weaker, as only 5 mL of the irradiated BSA:DNA mixture was
loaded, compared to 20 mL of the translin:DNA mixtures.
doi:10.1371/journal.pone.0033035.g006
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